CHRS Free Cash Flow
-$243.92MTTM · USD
Period ending:
CHRS FY Free Cash FlowUSD
$146.91M-$259.06M
2012-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
CHRS free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -138,513,000 | |
| -20,440,000 | |
| -175,170,000 | |
| -243,163,000 | |
| -38,721,000 | |
| 146,914,000 | |
| 15,458,000 | |
| -160,055,000 | |
| -204,859,000 | |
| -259,060,000 | |
| -114,154,000 | |
| -26,776,000 | |
| 15,050,000 | |
| -20,034,000 |
Compare free cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) free cash flow
- Bridgebio Pharma Inc (BBIO) free cash flow
- Brightspring Health Services Inc (BTSG) free cash flow
- Madrigal Pharmaceuticals Inc (MDGL) free cash flow
- Ensign Group Inc (ENSG) free cash flow
- Glaukos Corp (GKOS) free cash flow
- Vaxcyte Inc (PCVX) free cash flow
- Krystal Biotech Inc (KRYS) free cash flow
All CHRS financial metrics · CHRS stock overview · How to interpret financial metrics
